Cancer Biomarker Market Size, Share & Trends Analysis Report, by Type of Biomarker (HER2, MET, EGFR, PD-L1, NTRK, ALK, Novel Biomarkers and Other Biomarkers), Type of Cancer (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Thyroid Cancer, Bladder Cancer, Melanoma, Non-Hodgkins Lymphoma, Endometrial Cancer, Kidney Cancer and Leukemia), By Region, Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Cancer Biomarkers Market Snapshot Chapter 4. Global Cancer Biomarkers Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Type of Biomarker Estimates & Trend Analysis 5.1. by Type of Biomarker & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Biomarker: 5.2.1. HER2 5.2.2. MET 5.2.3. EGFR 5.2.4. PD-L1 5.2.5. NTRK 5.2.6. ALK 5.2.7. Novel Biomarkers 5.2.8. Other Biomarkers Chapter 6. Market Segmentation 2: by Type of Cancer Estimates & Trend Analysis 6.1. by Type of Cancer & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Cancer: 6.2.1. Breast Cancer 6.2.2. Prostate Cancer 6.2.3. Colorectum Cancer 6.2.4. Lung Cancer 6.2.5. Thyroid Cancer 6.2.6. Bladder Cancer 6.2.7. Melanoma 6.2.8. Non-Hodgkins Lymphoma 6.2.9. Endometrial Cancer 6.2.10. Kidney Cancer 6.2.11. Leukemia Chapter 7. Cancer Biomarkers Market Segmentation 6: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Biomarker, 2021-2034 7.1.2. North America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034 7.1.3. North America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 7.2. Europe 7.2.1. Europe Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Biomarker, 2021-2034 7.2.2. Europe Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034 7.2.3. Europe Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 7.3. Asia Pacific 7.3.1. Asia Pacific Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Biomarker, 2021-2034 7.3.2. Asia Pacific Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034 7.3.3. Asia Pacific Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 7.4. Latin America 7.4.1. Latin America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Biomarker, 2021-2034 7.4.2. Latin America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034 7.4.3. Latin America Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 7.5. Middle East & Africa 7.5.1. Middle East & Africa Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Biomarker, 2021-2034 7.5.2. Middle East & Africa Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034 7.5.3. Middle East & Africa Cancer Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Agilent 8.2.2. ARUP Laboratories 8.2.3. BioReference 8.2.4. Foundation Medicine 8.2.5. OncoDNA 8.2.6. Q² Solutions 8.2.7. Thermo Fisher Scientific 8.2.8. YuceBio 8.2.9. Asper Biogene 8.2.10. Caris Life Sciences 8.2.11. CeGaT 8.2.12. Genekor Medical 8.2.13. Guardant Health 8.2.14. Labcorp 8.2.15. MedGenome 8.2.16. NeoGenomics Laboratories 8.2.17. Nonacus 8.2.18. Oxford Gene Technology 8.2.19. Personal Genome Diagnostics 8.2.20. PhenoPath 8.2.21. Positive Biosciences 8.2.22. Quest Diagnostics 8.2.23. Tempus